- Home
- OPAD vs TPST Comparison
OPAD vs TPST Comparison
Compare OPAD & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAD
- TPST
- Stock Information
- Founded
- OPAD 2015
- TPST 2011
- Country
- OPAD United States
- TPST United States
- Employees
- OPAD N/A
- TPST N/A
- Industry
- OPAD Real Estate
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- OPAD Finance
- TPST Health Care
- Exchange
- OPAD Nasdaq
- TPST Nasdaq
- Market Cap
- OPAD 25.3M
- TPST 33.0M
- IPO Year
- OPAD N/A
- TPST N/A
- Fundamental
- Price
- OPAD $1.39
- TPST $6.95
- Analyst Decision
- OPAD Hold
- TPST Hold
- Analyst Count
- OPAD 5
- TPST 3
- Target Price
- OPAD $2.38
- TPST $30.00
- AVG Volume (30 Days)
- OPAD 141.6K
- TPST 90.3K
- Earning Date
- OPAD 08-04-2025
- TPST 08-07-2025
- Dividend Yield
- OPAD N/A
- TPST N/A
- EPS Growth
- OPAD N/A
- TPST N/A
- EPS
- OPAD N/A
- TPST N/A
- Revenue
- OPAD $794,159,000.00
- TPST N/A
- Revenue This Year
- OPAD N/A
- TPST N/A
- Revenue Next Year
- OPAD $40.79
- TPST N/A
- P/E Ratio
- OPAD N/A
- TPST N/A
- Revenue Growth
- OPAD N/A
- TPST N/A
- 52 Week Low
- OPAD $0.91
- TPST $5.35
- 52 Week High
- OPAD $5.13
- TPST $30.03
- Technical
- Relative Strength Index (RSI)
- OPAD 70.23
- TPST 46.97
- Support Level
- OPAD $0.91
- TPST $7.06
- Resistance Level
- OPAD $1.59
- TPST $7.64
- Average True Range (ATR)
- OPAD 0.13
- TPST 0.27
- MACD
- OPAD 0.06
- TPST 0.02
- Stochastic Oscillator
- OPAD 77.94
- TPST 31.91
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.